60760-322 : Kadian 20 mg Extended Release Capsule

NDC:	60760-322
Labeler:	St Marys Medical Park Pharmacy
Product Type:	Human Prescription Drug
Drug Name:	Kadian ER
Dosage Form:	Oral Capsule
Application #:	NDA020616
Rev. Date:	Dec 21, 2010
CSA Schedule:	CII (US) [1]

^[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:

Markings:	Kadian;20;mg
Shapes:	Capsule
Colors:	Yellow
Size (mm):	14
Segments: *	1
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

• 60760-322-30: 30 CAPSULE IN 1 BOTTLE (60760‑322‑30)
• 60760-322-60: 60 CAPSULE IN 1 BOTTLE (60760‑322‑60)

Active Ingredients:

• Morphine Sulfate

Inactive Ingredients:

• Hypromelloses
• Methacrylic Acid - Methyl Methacrylate Copolymer (1:1)
• Diethyl Phthalate
• Talc
• Starch, Corn
• Sucrose
• Gelatin
• Silicon Dioxide
• Sodium Lauryl Sulfate
• Titanium Dioxide
• D&c Yellow No. 10

Pharmaceutical Classes:

• Full Opioid Agonists [MoA]
• Opioid Agonist [EPC]

NDC QR Code

Scan the QR code below to easily reference this data in the future:



< Prev: 60760-319Next: 60760-323 >

Related Discussions: